These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33058635)

  • 1. [Developmental psychopharmacology: example of Prader-Willi syndrome].
    Consoli A; Tauber M; Cohen D
    Rev Prat; 2020 May; 70(5):507-508. PubMed ID: 33058635
    [No Abstract]   [Full Text] [Related]  

  • 2. Psychopharmacology of neurobehavioral disorders.
    Mooney LN; Dominick KC; Erickson CA
    Handb Clin Neurol; 2019; 165():383-390. PubMed ID: 31727225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of mazindol in two patients with Prader-Willi syndrome.
    Itoh M; Koeda T; Ohno K; Takeshita K
    Pediatr Neurol; 1995 Nov; 13(4):349-51. PubMed ID: 8771175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatropin therapy in adults with Prader-Willi syndrome.
    Höybye C; Thorén M
    Treat Endocrinol; 2004; 3(3):153-60. PubMed ID: 16026111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose homeostasis in Prader-Willi syndrome and potential implications of growth hormone therapy.
    Zipf WB
    Acta Paediatr Suppl; 1999 Dec; 88(433):115-7. PubMed ID: 10626560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate effectiveness in Prader-Willi syndrome.
    Smathers SA; Wilson JG; Nigro MA
    Pediatr Neurol; 2003 Feb; 28(2):130-3. PubMed ID: 12699864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sudden death in Prader-Willi syndrome: brief review of five additional cases. Concerning the article by U. Eiholzer et al.: Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS (Horm Res 2005;63:33-39).
    Bakker B; Maneatis T; Lippe B
    Horm Res; 2007; 67(4):203-4. PubMed ID: 17164585
    [No Abstract]   [Full Text] [Related]  

  • 8. ASD, ADHD, mental health conditions and psychopharmacology in neurogenetic syndromes: parent survey.
    Reilly C; Senior J; Murtagh L
    J Intellect Disabil Res; 2015 Apr; 59(4):307-18. PubMed ID: 24965264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain developmental abnormalities in Prader-Willi syndrome detected by diffusion tensor imaging.
    Yamada K; Matsuzawa H; Uchiyama M; Kwee IL; Nakada T
    Pediatrics; 2006 Aug; 118(2):e442-8. PubMed ID: 16882785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prader-Willi syndrome].
    Sarda P
    Soins Pediatr Pueric; 2013; (274):20-3. PubMed ID: 24228330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating diabetes mellitus in Prader-Willi syndrome with Exenatide.
    Seetho IW; Jones G; Thomson GA; Fernando DJ
    Diabetes Res Clin Pract; 2011 Apr; 92(1):e1-2. PubMed ID: 21227526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prader-Willi syndrome: medical prevention and behavioral challenges.
    Benarroch F; Hirsch HJ; Genstil L; Landau YE; Gross-Tsur V
    Child Adolesc Psychiatr Clin N Am; 2007 Jul; 16(3):695-708. PubMed ID: 17562587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body composition in Prader-Willi syndrome: assessment and effects of growth hormone administration.
    Davies PS
    Acta Paediatr Suppl; 1999 Dec; 88(433):105-8. PubMed ID: 10626557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and clinical advances in Prader-Willi syndrome.
    Wharton RH; Loechner KJ
    Curr Opin Pediatr; 1996 Dec; 8(6):618-24. PubMed ID: 9018447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone treatment improves vitality and behavioural issues in children with Prader-Willi syndrome.
    Böhm B; Ritzén EM; Lindgren AC
    Acta Paediatr; 2015 Jan; 104(1):59-67. PubMed ID: 25263744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone, gender and face shape in Prader-Willi syndrome.
    de Souza MA; McAllister C; Suttie M; Perrotta C; Mattina T; Faravelli F; Forzano F; Holland A; Hammond P
    Am J Med Genet A; 2013 Oct; 161A(10):2453-63. PubMed ID: 23918156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapeutic approaches for Prader-Willi Syndrome.
    Jerome L
    Can J Psychiatry; 1989 Nov; 34(8):845-6. PubMed ID: 2819652
    [No Abstract]   [Full Text] [Related]  

  • 18. Somatropin in Prader-Willi syndrome.
    Prescrire Int; 2004 Feb; 13(69):21. PubMed ID: 15055219
    [No Abstract]   [Full Text] [Related]  

  • 19. [Psychological management of a patient with Prader Willi syndrome: case study of a young Moroccan girl].
    Benchikhi L; Nafiaa H; Zaroual A; Ouanass A
    Pan Afr Med J; 2019; 33():115. PubMed ID: 31489093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality in Prader-Willi syndrome.
    Einfeld SL; Kavanagh SJ; Smith A; Evans EJ; Tonge BJ; Taffe J
    Am J Ment Retard; 2006 May; 111(3):193-8. PubMed ID: 16597186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.